
Marsha M. Tsay
Examiner (ID: 10087, Phone: (571)272-2938 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1119 |
| Issued Applications | 471 |
| Pending Applications | 134 |
| Abandoned Applications | 540 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20264375
[patent_doc_number] => 12435353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Biomarker assay for use in monitoring autism
[patent_app_type] => utility
[patent_app_number] => 18/470985
[patent_app_country] => US
[patent_app_date] => 2023-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18470985
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/470985 | Biomarker assay for use in monitoring autism | Sep 19, 2023 | Issued |
Array
(
[id] => 20068887
[patent_doc_number] => 20250207109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-26
[patent_title] => ENGINEERED SPLIT DHFR-BASED METHODS AND SYSTEMS FOR SELECTING CELLS THAT HAVE STABLY ACQUIRED A HETEROLOGOUS POLYNUCLEOTIDE
[patent_app_type] => utility
[patent_app_number] => 18/709446
[patent_app_country] => US
[patent_app_date] => 2023-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18709446
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/709446 | ENGINEERED SPLIT DHFR-BASED METHODS AND SYSTEMS FOR SELECTING CELLS THAT HAVE STABLY ACQUIRED A HETEROLOGOUS POLYNUCLEOTIDE | Sep 19, 2023 | Pending |
Array
(
[id] => 19067199
[patent_doc_number] => 20240101625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE
[patent_app_type] => utility
[patent_app_number] => 18/461658
[patent_app_country] => US
[patent_app_date] => 2023-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16150
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18461658
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/461658 | EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE | Sep 5, 2023 | Abandoned |
Array
(
[id] => 19390723
[patent_doc_number] => 20240280593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS
[patent_app_type] => utility
[patent_app_number] => 18/231880
[patent_app_country] => US
[patent_app_date] => 2023-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18231880
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/231880 | METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS | Aug 8, 2023 | Abandoned |
Array
(
[id] => 18754357
[patent_doc_number] => 20230357762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => EUGLOBULIN-BASED METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE
[patent_app_type] => utility
[patent_app_number] => 18/351241
[patent_app_country] => US
[patent_app_date] => 2023-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18351241
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/351241 | EUGLOBULIN-BASED METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE | Jul 11, 2023 | Pending |
Array
(
[id] => 18972231
[patent_doc_number] => 20240052323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => MODIFIED TRANSGLUTAMINASE
[patent_app_type] => utility
[patent_app_number] => 18/212427
[patent_app_country] => US
[patent_app_date] => 2023-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18212427
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/212427 | MODIFIED TRANSGLUTAMINASE | Jun 20, 2023 | Pending |
Array
(
[id] => 18726234
[patent_doc_number] => 20230340501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => COORDINATED COEXPRESSION OF THROMBIN
[patent_app_type] => utility
[patent_app_number] => 18/310317
[patent_app_country] => US
[patent_app_date] => 2023-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28116
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18310317
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/310317 | COORDINATED COEXPRESSION OF THROMBIN | Apr 30, 2023 | Abandoned |
Array
(
[id] => 18649763
[patent_doc_number] => 20230295584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => BIOSENSING ELEMENT BASED ON SPECIFIC BINDING OF CBM AND CELLULOSE
[patent_app_type] => utility
[patent_app_number] => 18/131968
[patent_app_country] => US
[patent_app_date] => 2023-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18131968
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/131968 | BIOSENSING ELEMENT BASED ON SPECIFIC BINDING OF CBM AND CELLULOSE | Apr 6, 2023 | Pending |
Array
(
[id] => 18649763
[patent_doc_number] => 20230295584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => BIOSENSING ELEMENT BASED ON SPECIFIC BINDING OF CBM AND CELLULOSE
[patent_app_type] => utility
[patent_app_number] => 18/131968
[patent_app_country] => US
[patent_app_date] => 2023-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18131968
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/131968 | BIOSENSING ELEMENT BASED ON SPECIFIC BINDING OF CBM AND CELLULOSE | Apr 6, 2023 | Pending |
Array
(
[id] => 18860272
[patent_doc_number] => 20230414706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/296454
[patent_app_country] => US
[patent_app_date] => 2023-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296454
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296454 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES | Apr 5, 2023 | Pending |
Array
(
[id] => 18860272
[patent_doc_number] => 20230414706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/296454
[patent_app_country] => US
[patent_app_date] => 2023-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296454
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296454 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES | Apr 5, 2023 | Pending |
Array
(
[id] => 18647986
[patent_doc_number] => 20230293769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => ENGINEERED TISSUES HAVING STRUCTURAL COMPONENTS EMBEDDED THEREIN, AND METHODS OF MAKING AND USING
[patent_app_type] => utility
[patent_app_number] => 18/123157
[patent_app_country] => US
[patent_app_date] => 2023-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18123157
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/123157 | ENGINEERED TISSUES HAVING STRUCTURAL COMPONENTS EMBEDDED THEREIN, AND METHODS OF MAKING AND USING | Mar 16, 2023 | Abandoned |
Array
(
[id] => 18552403
[patent_doc_number] => 20230250412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => Compositions and Methods for Modulating Factor IX Function
[patent_app_type] => utility
[patent_app_number] => 18/176546
[patent_app_country] => US
[patent_app_date] => 2023-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18176546
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/176546 | Compositions and Methods for Modulating Factor IX Function | Feb 28, 2023 | Pending |
Array
(
[id] => 18955142
[patent_doc_number] => 20240043469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => MANUFACTURE OF ENDOTOXIN-FREE HEMOGLOBIN-BASED DRUG SUBSTANCE AND METHOD FOR ENDOTOXIN-FREE PROTEIN PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 18/115724
[patent_app_country] => US
[patent_app_date] => 2023-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18115724
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/115724 | MANUFACTURE OF ENDOTOXIN-FREE HEMOGLOBIN-BASED DRUG SUBSTANCE AND METHOD FOR ENDOTOXIN-FREE PROTEIN PURIFICATION | Feb 27, 2023 | Abandoned |
Array
(
[id] => 19404045
[patent_doc_number] => 20240287556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => USING BIOSOURCED RAWS FROM WASTE STREAMS TO MAKE SOURCE MATERIALS FOR OILFIELD CHEMICAL MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 18/115585
[patent_app_country] => US
[patent_app_date] => 2023-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18115585
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/115585 | USING BIOSOURCED RAWS FROM WASTE STREAMS TO MAKE SOURCE MATERIALS FOR OILFIELD CHEMICAL MANUFACTURE | Feb 27, 2023 | Abandoned |
Array
(
[id] => 18692955
[patent_doc_number] => 20230323314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => INCREASING PRODUCTIVITY OF E. COLI HOST CELLS THAT FUNCTIONALLY EXPRESS P450 ENZYMES
[patent_app_type] => utility
[patent_app_number] => 18/161938
[patent_app_country] => US
[patent_app_date] => 2023-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18161938
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/161938 | INCREASING PRODUCTIVITY OF E. COLI HOST CELLS THAT FUNCTIONALLY EXPRESS P450 ENZYMES | Jan 30, 2023 | Pending |
Array
(
[id] => 18390281
[patent_doc_number] => 20230158499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood
[patent_app_type] => utility
[patent_app_number] => 18/159283
[patent_app_country] => US
[patent_app_date] => 2023-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159283
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159283 | Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood | Jan 24, 2023 | Abandoned |
Array
(
[id] => 18404904
[patent_doc_number] => 20230166255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood
[patent_app_type] => utility
[patent_app_number] => 18/159281
[patent_app_country] => US
[patent_app_date] => 2023-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159281
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159281 | Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood | Jan 24, 2023 | Pending |
Array
(
[id] => 18390280
[patent_doc_number] => 20230158498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood
[patent_app_type] => utility
[patent_app_number] => 18/159276
[patent_app_country] => US
[patent_app_date] => 2023-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159276
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159276 | Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood | Jan 24, 2023 | Abandoned |
Array
(
[id] => 18709574
[patent_doc_number] => 20230332194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING ADIPATE, 6-AMINOCAPROATE, HEXAMETHYLENEDIAMINE OR CAPROLACTAM RELATED THERETO
[patent_app_type] => utility
[patent_app_number] => 18/158680
[patent_app_country] => US
[patent_app_date] => 2023-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18158680
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/158680 | MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING ADIPATE, 6-AMINOCAPROATE, HEXAMETHYLENEDIAMINE OR CAPROLACTAM RELATED THERETO | Jan 23, 2023 | Abandoned |